Abstract: As multi-sensor technology advances and data storage and processing capabilities improve, multi-sensor signals can provide a more comprehensive and multi-angle data perspective. This ...

Abstract: Timely detection and accurate diagnosis of faults in technological processes can significantly reduce production costs in manufacturing. Modern industrial equipment, equipped with numerous ...

Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.

Shares of CRISPR Therapeutics CRSP were up 3.7% yesterday after the company announced encouraging updates from ongoing studies on its next-generation CAR-T therapy candidate, zugocaptagene geleucel or ...

Anyone possessing an ageing mobile that's presently linked to the O2 network must upgrade immediately. The well-known British provider has just delivered a final alert, and disregarding it could ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two ...

Like many states, Pennsylvania is weighing a “bell-to-bell” mandatory ban on cell phones in school. Like a social contagion, these laws have spread despite lack of evidence that they are useful. For ...

Good morning, and welcome to the Kyverna Therapeutics Investor Conference Call. [Operator Instructions] Please note that this call is being recorded. I would now like to introduce Jessica Serra, Head ...

Virgin Media O2 has released its 2025 Year in Review, revealing record levels of data consumption in the UK, including an 8 per cent rise in broadband usage and an 18 per cent rise in mobile traffic.

Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome, supporting a bullish outlook. KYTX's Miv-cel achieved significant clinical improvements and ...